Rakicidin A: A hypoxia-selective cytotoxin

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 2, 2007, Pages 261-265

  Yamazaki, Yohko ^a   Kunimoto, Setsuko ^a   Ikeda, Daishiro ^a  

^a Numazu Bio Medical Research Institute   (Japan)

Author keywords

Hypoxia; Hypoxia selective cytotoxicity; Rakicidin A

Indexed keywords

3' DEAMINO 2' FLUORO 3' HYDROXYDOXORUBICIN 14 PIMELATE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BLEOMYCIN A2; CAMPTOTHECIN; CHLORAMBUCIL; CISPLATIN; COBALT CHLORIDE; CYTOTOXIN; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; HYPOXIA INDUCIBLE FACTOR 1; MELPHALAN; MITOMYCIN C; PACLITAXEL; RAKICIDIN A; RUFOCROMOMYCIN; TUBERCIDIN; UNCLASSIFIED DRUG; VINBLASTINE; ZINOSTATIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CHO CELL; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; DRUG SELECTIVITY; HUMAN; HUMAN CELL; HYPOXIA; MICROORGANISM; NONHUMAN; SOLID TUMOR; TRANSCRIPTION REGULATION;

ANIMALS; ANOXIA; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHO CELLS; CRICETINAE; CRICETULUS; DRUG RESISTANCE, NEOPLASM; HUMANS; LIPOPEPTIDES; PEPTIDES, CYCLIC;

EID: 33846999312     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.261     Document Type: Article

References (21)

1. Vaupel P., Schlenger K., Knoop C., Hockel M., Cancer Res., 51, 3316-3322 (1991).
2. Hockel M., Schlenger K., Knoop C., Vaupel P., Cancer Res., 51, 6098-6102 (1991).
3. Thomlinson R. H., Gray L. H., Br. J. Cancer, 4, 539-549 (1955).
4. Tannock I. F., Br. J. Cancer, 2, 258-273 (1968).
5. Moulder J. E., Rockwell S., Cancer Metastasis Rev., 5, 313-341 (1987).
6. Brown J. M., Wilson W. R., Nat. Rev. Cancer, 4, 437-447 (2004).
7. Hockel M., Schlenger K., Aral B., Mitze M., Schaffer U., Vaupel P., Cancer Res., 56, 4509-4515 (1996).
8. von Pawel J., von Roemeling R., Gatzemeier U., Boyer M., Elisson L. O., Clark P., Talbot D., Rey A., Butler T. W., Hirsh V., Olver I., Bergman B., Ayoub J., Richardson G., Dunlop D., Arcenas A., Vescio R., Viallet J., Treat J., J. Clin. Oncol., 18, 1351-1359 (2000).
9. Yamazaki Y., Egawa K., Nose K., Kunimoto S., Takeuchi T., Biol. Pharm. Bull., 26, 417-420 (2003).
10. Penketh P. G., Hodnick W. F., Belcourt M. F., Shyam K., Sherman D. H., Sartorelli A. C., J. Biol. Chem., 276, 34445-34452 (2001).
11. McBrien K. D., Berry R. L., Lowe S. E., Neddermann K. M., Bursuker I., Huang S., Klohr S. E., Leet J. E., J. Antibiot., 48, 1446-1452 (1995).
12. Wang G. L., Semenza G. L., J. Biol. Chem., 270, 1230-1237 (1995).
13. Semenza G. L., Nat. Rev. Cancer, 3, 721-732 (2003).
14. Comerford K. M., Wallace T. J., Karhausen J., Louis N. A., Montalto M. C., Colgan S. P., Cancer Res., 62, 3387-3394 (2002).
15. Yamazaki Y., Someno T., Minamiguchi K., Kawada M., Momose I., Kinoshita N., Doi H., Ikeda D., J. Antibiot., 59, 693-697 (2006).
16. Kennedy K. A., Rockwell S., Sartorelli A. C., Cancer Res., 40, 2356-2360 (1980).
17. Rauth A. M., Mohindra J. K., Tannock I. F., Cancer Res., 43, 4154-4158 (1983).
18. Miller D. S., Laszlo J., McCarty K. S., Guild W. R., Hochstein P., Cancer Res., 27, 632-638 (1967).
19. Doroshow J. H., Proc. Natl. Acad. Sci. U.S.A., 83, 4514-4518 (1986).
20. Sinha B. K., Mimnaugh E. G., Free Radic. Biol. Med., 8, 567-581 (1990).
21. Wardman P., Dennis M. F., Everett S. A., Patel K. B., Stratford M. R., Tracy M., Biochem. Soc. Symp., 61, 171-194 (1995).